Immunomedics Inc (IMMU.O)

IMMU.O on Consolidated Issue listed on NASDAQ Global Market

3.27USD
28 Jul 2014
Price Change (% chg)

$-0.07 (-2.10%)
Prev Close
$3.34
Open
$3.34
Day's High
$3.38
Day's Low
$3.25
Volume
52,954
Avg. Vol
--
52-wk High
--
52-wk Low
--

IMMU.O

Chart for IMMU.O

About

Immunomedics, Inc. is a biopharmaceutical company focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. The Company has developed a number of advanced technologies that allow the Company to create humanized antibodies that can be used either... (more)

Overall

Beta: 0.96
Market Cap (Mil.): $278.91
Shares Outstanding (Mil.): 83.51
Dividend: --
Yield (%): --

Financials

  IMMU.O Industry Sector
P/E (TTM): -- 106.36 36.09
EPS (TTM): -0.38 -- --
ROI: -93.20 -0.18 18.19
ROE: -97.00 -1.06 19.06
Search Stocks

Competitors

  Price Change
Pfizer Inc. (PFE.N) $30.00 -0.19
Roche Holding Ltd. (ROG.VX) CHF265.40 -1.60
Bayer AG (BAYGn.DE) €99.10 +0.39
Bayer AG (BAYE.F) -- --
AstraZeneca plc (AZN.L) 4,373.00p -19.00
GlaxoSmithKline plc (GSK.L) 1,412.93p -10.00
Eli Lilly and Co (LLY.N) $63.11 -0.67
Bristol-Myers Squibb Co (BMY.N) $49.38 -0.01
Bristol-Myers Squibb Co (BMYMP.PK) $829.72 -58.28
Amgen, Inc. (AMGN.OQ) $121.87 -0.97

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks